Job Responsibilities
- Work with senior colleagues in the team to provide thought-leadership to institutional clients with respect to the Pharma & Biotech sector with potential for stock coverage based on candidate readiness
- Maintain and update valuation models and databases
- Build and maintain therapeutic models for different diseases
- Prepare materials for the regular publication of research reports, including data analysis and presentation
- Contribute to the writing of research reports, including quarterly results alerts, stock reports, and thematic pieces
- Communicate with institutional investors and company representatives, as well as internal clients (Sales, Sales-Traders, and Traders)
- Stay abreast of company and industry developments
Required Qualifications, Capabilities, and Skills
- Strong interest in the Pharma & Biotechand a willingness to specialize in this area.
- Excellent communication skills, both verbal and written; you can engage and influence partners and stakeholders
- Enthusiasm for a team-focused environment where each individual’s insight and expertise is valued
- An analytical approach to building and maintaining financial models
- Strong numeracy skills
- Great attention to detail
- Relationship-building skills — you should feel comfortable connecting with a wide range of individuals, have the ability to communicate clearly, concisely, and confidently both to colleagues and external clients, and possess a talent for distilling complex issues into specific conclusion
Preferred qualifications, capabilities, and skills
- Strong modelling skills, with the ability to forecast
- Degree in Physical or Life Sciences
- Experience in the Pharma Industry, Accounting or Consulting advantageous but not essential
This role encompasses the performance of UK regulated activity. The successful candidate will therefore be subject to meeting UK regulatory requirements in the assessment of fitness, propriety, knowledge and competence (as assessed by the Firm) and (where appropriate) approval by the UK Financial Conduct Authority and/or the Prudential Regulation Authority to carry out such activities.